Fee for scientific advice: classification of a medicinal productU.K.
This section has no associated Explanatory Memorandum
5.—(1) The fee payable by a person with whom the licensing authority holds a meeting to provide scientific advice in connection with the classification of a relevant medicinal product, is—
(a)£2,763, if the advice relates to a product which, if reclassified, will be available on general sale; and
(b)£3,624, if the advice relates to a product which, if reclassified, will be available without a prescription from a pharmacy.
(2) For the purposes of this regulation, a product is on general sale if it is a medicinal product subject to general sale within the meaning of regulation 5(1) of the Human Medicines Regulations (classification of medicinal products for general sale).